Exhibit
      31.2





**CERTIFICATION
      OF PRINCIPAL EXECUTIVE AND
      OFFICERS**


**PURSUANT
      TO RULES 13A-14 AND 15D-14**


**OF
      THE SECURITIES AND EXCHANGE ACT OF 1934**








I,
      Haijing (Carrie) Wang, Chief Financial Officer, certify that:





1.
        I have
        reviewed this amended quarterly report on Form 10-QSB/A of AOB Biotech,
        Inc.;
 
 2.
        Based
        on my knowledge, this amended quarterly report does not contain any untrue
        statements of a material fact or omit to state a material fact necessary
        to make
        the statements made, in light of the circumstances under which such statements
        were made, not misleading with respect to the period covered by this amended
        quarterly report;
 
 3.
        Based
        on my knowledge, the financial statements, and other financial information
        included in this amended quarterly report, fairly present in all material
        respects the financial condition, results of operations and cash flows of
        the
        registrant as of, and for, the periods presented in this amended quarterly
        report;
 
 4.
        The
        registrant's other certifying officers and I are responsible for establishing
        and maintaining disclosure controls and procedures (as defined in Exchange
        Act
        Rules 13a-14 and 15d-14) for the registrant and we have:
 
 a)
            designed
                such disclosure controls and procedures to ensure that material
                information relating to the registrant, including its consolidated
                subsidiaries, is made known to us by others within those entities,
                particularly during the period in which this amended quarterly report
                is
                being prepared; 
 b)
            evaluated
                the effectiveness of the registrant's disclosure controls and procedures
                as of a date within 90 days prior to the filing date of this amended
                quarterly report (the "Evaluation Date");
                and 
 c)
            presented
                in this quarterly report our conclusions about the effectiveness
                of the
                disclosure controls and procedures based on our evaluation as of
                the
                Evaluation Date; 
 5.
        The
        registrant's other certifying officers and I have disclosed, based on our
        most
        recent evaluation, to the registrant's auditors and the registrant's board
        of
        directors (or persons performing the equivalent functions):
 
 a)
            all
                significant deficiencies in the design or operation of internal controls
                which could adversely affect the registrant's ability to record,
                process,
                summarize and report financial data and have identified for the
                registrant's auditors any material weaknesses in internal controls;
                and 
 b)
            any
                fraud, whether or not material, that involves management or other
                employees who have a significant role in the registrant's internal
                controls; and 
 6.
        The
        registrant's other certifying officers and I have indicated in this amended
        quarterly report whether or not there were significant changes in internal
        controls or in other factors that could significantly affect internal controls
        subsequent to the date or our most recent evaluation, including any corrective
        actions with regard to significant deficiencies and material
        weaknesses.


February
                1, 2007
            ***/s/
                Haijing (Carrie) Wang****Haijing
                (Carrie) Wang**Chief
                Financial Officer*